Please upgrade your browser.
Since 1990, the Kidney Cancer Association has dedicated itself to the eradication of kidney cancer and to improving care, stimulating research, and increasing survival of kidney cancer patients worldwide. We are the only organization of its kind to serve kidney cancer patients, their families, and physicians around the world. As we work to globalize our organization, we hope to continue our collaboration with you so that we may be of further assistance to you and your patients.
This suggests that bevacizumab might have a promising future in the treatment of psoriasis and PsA.
There is aan apparent link between exposure to aristolochic acid and incidence of kidney cancer, particularly in Romania.
Dr. David Schulsinger spearheads pilot study for ablation of renal cell carcinoma with SonaCare Medical’s Sonatherm® Laparoscopic Soft Tissue HIFU Surgical Ablation Device.
Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the findings suggest that cancer screening guidelines might be re-evaluated to facilitate the early diagnosis and prompt treatment of breast cancer among Wilms tumor survivors.
Brian Rini, MD, comments that researchers are currently developing biomarkers that may help determine whether a disease is susceptible to PD-1 inhibition, potentially aiding clinicians in deciding whether to initiate a checkpoint inhibitor and a TKI in sequence, or concurrently.
5-6 March 2015, Moscow
Read the current issue online.
Map the locations of survivors nearest you. Join the online conversation on Inspire's new Kidney Cancer Community.
Bristol-Myers Squibb Company (NYSE: BMY) and The University of Texas MD Anderson Cancer Center today announced a novel clinical research collaboration to evaluate multiple immunotherapies...
|Powered by NeonCRM|